XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic

Open Access

Peer-reviewed

Research Article

Akvile Haeckel,

Affiliation Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
⨯
Franziska Appler,

Affiliation nanoPET Pharma, Berlin, Germany
⨯
Angela Ariza de Schellenberger,

Affiliation Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
⨯
Eyk Schellenberger

* E-mail: eyk.schellenberger@charite.de

Affiliation Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
⨯

Reader Comments (0)

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell growth
Is the Subject Area "Cell growth" applicable to this article?

Thanks for your feedback.
Cytostatics
Is the Subject Area "Cytostatics" applicable to this article?

Thanks for your feedback.
Polypeptides
Is the Subject Area "Polypeptides" applicable to this article?

Thanks for your feedback.
Thyroid carcinoma
Is the Subject Area "Thyroid carcinoma" applicable to this article?

Thanks for your feedback.